268 results on '"Kukreti, Vishal"'
Search Results
2. The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma
3. A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
4. Very late relapse in Hodgkin lymphoma: Characterizing an understudied population
5. Implementation of medication reconciliation in outpatient cancer care
6. Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills
7. Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities
8. Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?
9. The I-Can Manage web-based cancer self-management program targeting treatment toxicities and health behaviours: Human centred co-design approach and cognitive-think aloud usability testing (Preprint)
10. Human centered co-design and usability testing of a web-based cancer self-management education program (I-Can Manage) targeting treatment toxicities and health behaviours (Preprint)
11. Chromosome 1q Abnormalities Are Not an Independent Predictor of Survival in Multiple Myeloma
12. Clinical Characteristics and Disease Outcomes in Primary Bone Lymphoma: Retrospective Study
13. Frailty in Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study
14. Correlation Amongst Scoring of Various Frailty Tools in Myeloma Patients Undergoing Autologous Stem Cell Transplantation
15. Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation
16. Implementation and Impact of Choosing Wisely Recommendations in Oncology
17. Clinical utility of interim CT scans in patients receiving chemoimmuntherapy for first line treatment of follicular lymphoma
18. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma
19. Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study
20. Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume
21. Overview of Head and Neck Lymphomas
22. Light Chain Amyloidosis (AL) Associated With B Cell Lymphoma a Single Center Experience
23. Kinetics of response to first‐ and second‐line therapies in multiple myeloma: Assessment by both M‐spikes and light chains
24. Outcomes in Relapsed/Refractory Burkitt Lymphoma: A Multi-Centre Canadian Experience
25. Risk Stratification for Relapsed/Refractory Classical Hodgkin Lymphoma Integrating Pretransplant Deauville Score and Residual Metabolic Tumor Volume
26. Myeloma Patients with Deletion of 17p: Impact of Tandem Transplant and Clone Size
27. Clinical Significance of Clonal Hematopoiesis in the Setting of Autologous Stem Cell Transplantation for Lymphoma
28. Supermobilizers with High CD34 + Cell Collection for Autologous Transplant and Impact on Survival Outcomes in Multiple Myeloma
29. Quality of Life and Caregiver Burden in Patients and Their Caregivers Undergoing Outpatient Autologous Stem Cell Transplantation Compared to Inpatient Transplantation
30. Recovery of a quality improvement project during the COVID pandemic.
31. Implementation and impact of Choosing Wisely recommendations in oncology: A scoping review.
32. Fixed duration vs. prolonged duration treatment after first line therapy in patients with systemic light chain amyloidosis
33. A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma
34. Clinical utility of interim CT scans in patients receiving bendamustine and rituximab for first line treatment of follicular lymphoma.
35. Evolving Best Practice for Take-Home Cancer Drugs
36. Tandem Transplantation in Myeloma Patients with High Risk Cytogenetics: A 10 Year Single-Centre Experience
37. The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma
38. A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score
39. Five biopsies, one diagnosis: challenges in idiopathic multicentric Castleman disease
40. A Case of Rapid Deterioration with Marked Hypergammaglobulinemia
41. The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database
42. Improving medication reconciliation in ambulatory cancer care.
43. Current state assessment of the organization and delivery of systemic treatment in Ontario.
44. Syngeneic transplants for multiple myeloma – a single center experience and review of the literature
45. Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma
46. Feasibility randomised controlled trial of remote symptom chemotherapy toxicity monitoring using the Canadian adapted Advanced Symptom Management System (ASyMS-Can): a study protocol
47. An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines
48. Evaluation of Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnosis Clinic
49. Bortezomib-Based Induction, Augmented Conditioning with Busulfan and Melphalan + ASCT and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma: Long-Term Results of the National Canadian Mcrn-001 Study
50. The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.